444583-13-5 Usage
Molecular structure
2-(2-(tert-Butoxycarbonyl)isoindolin-1-yl)acetic acid is a complex organic compound with a unique molecular structure.
Protected form of amino acid
The presence of the tert-Butoxycarbonyl group makes this compound a protected form of an amino acid, which provides stability and utility in synthetic reactions.
Steric and electronic effects
The isoindolin-1-yl group adds steric and electronic effects to the molecule, which influences its reactivity and properties.
Carboxylic acid functionality
As a derivative of acetic acid, this compound possesses carboxylic acid functionality, making it suitable for use in organic synthesis and pharmaceutical research.
Value in drug and material development
The unique properties and reactivity of 2-(2-(tert-Butoxycarbonyl)isoindolin-1-yl)acetic acid make it valuable in the design and development of new drugs and materials.
Check Digit Verification of cas no
The CAS Registry Mumber 444583-13-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,4,4,5,8 and 3 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 444583-13:
(8*4)+(7*4)+(6*4)+(5*5)+(4*8)+(3*3)+(2*1)+(1*3)=155
155 % 10 = 5
So 444583-13-5 is a valid CAS Registry Number.
InChI:InChI=1/C15H19NO4/c1-15(2,3)20-14(19)16-9-10-6-4-5-7-11(10)12(16)8-13(17)18/h4-7,12H,8-9H2,1-3H3,(H,17,18)
444583-13-5Relevant articles and documents
COMPLEMENT PATHWAY MODULATORS AND USES THEREOF
-
Page/Page column 87; 88, (2014/01/09)
The present invention provides a compound of formula I a method for manufacturing the compounds of the invention, and its therapeutic uses as inhibitor of the complement alternative pathway and particularly as inhibitor of Factor B for the treatment of e.g. age-related macular degeneration and diabetic retinopathy. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
